Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • Log out
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportPIDS: Data Analysis & Dosimetry

Multicenter Clinical Validation of an Artificial Intelligence-based Tool for Myocardial Blood Flow Parametric Mapping to Diagnose Coronary Artery Disease with Rb-82 Positron Emission Tomography

Eric Moulton, Laura Gagliano, Ran Klein, Matthieu Pelletier-galarneau, Rob Beanlands and Robert Dekemp
Journal of Nuclear Medicine June 2025, 66 (supplement 1) 252017;
Eric Moulton
1jubilant radiopharma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Laura Gagliano
1jubilant radiopharma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ran Klein
2the ottawa hospital
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Matthieu Pelletier-galarneau
3montreal heart institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rob Beanlands
4university of ottawa heart institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Robert Dekemp
5uottawa heart institute
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
Loading

Abstract

252017

Introduction: Several techniques have been proposed to generate 3D parametric maps of myocardial blood flow (MBF) for 82Rb positron emission tomography (PET). Artificial intelligence (AI), in particular, has shown to be a strong candidate method due to the high speed of image generation and accuracy in reproducing the results from conventional nonlinear least-squares regression of the one tissue compartment model. Previous studies have generally validated different methodologies of parametric mapping from an analytic point-of-view by correlating the MBF values obtained with reference 2D polar map processing and 3D parametric maps for the whole left ventricle (LV) and the three vessel territories (LAD, RCA, and LCx). However, no study has yet to verify that parametric map-derived MBF values for 82Rb PET correlate with the presence of coronary artery disease (CAD). In this study, we validated a previously trained AI model to perform MBF parametric mapping by evaluating its diagnostic ability to predict CAD and compared its performance with traditional polar map kinetic modeling.

Methods: Our dataset comprised N=3,253 patients who underwent rest and stress 82Rb cardiac PET studies and invasive coronary angiography (ICA) within three months at two centers (center A: N=1,518 and center B: N=1,735). The only exclusion criteria were patients with previous bypass surgery. Conventional 2D polar processing was performed using FlowQuant to generate MBF and myocardial flow reserve (MFR) polar maps as well as arterial input functions. These same arterial input functions were used to generate MBF parametric maps for the same patients using an AI model previously trained previously on N=550 independent patients from center A. In that respect, the center B data served as a completely independent external validation site. Patient-specific LV segmentations were used to bring the MBF parametric maps into polar map space for calculation of whole LV and vessel-wise metrics. Using a normative database of N=40 low-likelihood patients for CAD, total perfusion deficit (TPD) and focally impaired myocardium extent from an integrated myocardial flow reserve (iMFR) map were calculated for reference polar map processing and parametric mapping of patients from both centers. For each metric and image processing method (i.e., conventional polar vs 3D parametric mapping), we trained and evaluated a logistic regression model with 5-fold cross validation to predict significant stenosis ≥ 70%. The receiver operator characteristic (ROC) area under the curve (AUC) across the test fold predictions against ground truth labels was computed for both models and compared using permutation tests.

Results: CAD prevalence was 77.3% in center A and 73.9% in center B. For all models, there were no significant differences in the AUC from the parametric- or polar-derived TPD or iMFR either at the whole LV or per-vessel level for either center, with highly overlapping confidence intervals (average ΔAUC=0.005±0.005, p>0.05 for all). The AUCs for the models between both sites were comparable, ranging from 0.67-0.76 depending on the vessel territory and metric, corroborating the robustness of TPD and iMFR for diagnosing significant obstructive disease in these unselected general patient populations.

Conclusions: We have provided a large multicenter clinical validation of our AI model for deriving 3D MBF parametric maps, demonstrating that they recover the same whole-LV and vessel-wise blood flow information as conventional polar map processing. These maps can thus be used reliably for accurate quantification of MBF to effectively diagnose patients with significant stenosis due to CAD.

Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Figure
  • Download figure
  • Open in new tab
  • Download powerpoint
Previous
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 66, Issue supplement 1
June 1, 2025
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Multicenter Clinical Validation of an Artificial Intelligence-based Tool for Myocardial Blood Flow Parametric Mapping to Diagnose Coronary Artery Disease with Rb-82 Positron Emission Tomography
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
Multicenter Clinical Validation of an Artificial Intelligence-based Tool for Myocardial Blood Flow Parametric Mapping to Diagnose Coronary Artery Disease with Rb-82 Positron Emission Tomography
Eric Moulton, Laura Gagliano, Ran Klein, Matthieu Pelletier-galarneau, Rob Beanlands, Robert Dekemp
Journal of Nuclear Medicine Jun 2025, 66 (supplement 1) 252017;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Multicenter Clinical Validation of an Artificial Intelligence-based Tool for Myocardial Blood Flow Parametric Mapping to Diagnose Coronary Artery Disease with Rb-82 Positron Emission Tomography
Eric Moulton, Laura Gagliano, Ran Klein, Matthieu Pelletier-galarneau, Rob Beanlands, Robert Dekemp
Journal of Nuclear Medicine Jun 2025, 66 (supplement 1) 252017;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Integrating Radiomic Features and Graph Neural Networks for Single Time-Point Dosimetry in Lu-177 PSMA Therapy
  • Introducing MIRDrpt: A freely Accessible Worksheet for Standardized Dosimetry and Bioeffect Metrics – 177Lu DOTATATE Implementation
Show more PIDS: Data Analysis & Dosimetry

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire